In summary, indicators of tumour and host biology such as Gas6, CD68 and Notch are helpful for improving the prediction of prognosis after NSCLC, but MMP2 and Cox2 were of no clinical value in the present study. The gene discussed is MMP2; the disease is non-small cell lung carcinoma.